pyrazolanthrone has been researched along with Lymphoproliferative Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kieser, A; Kutz, H; Reisbach, G; Schultheiss, U | 1 |
1 other study(ies) available for pyrazolanthrone and Lymphoproliferative Disorders
| Article | Year |
|---|---|
The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus.
Topics: Animals; Anthracenes; B-Lymphocytes; Cell Line; Cell Line, Transformed; Cell Transformation, Viral; Epstein-Barr Virus Infections; Fibroblasts; Herpesvirus 4, Human; Humans; JNK Mitogen-Activated Protein Kinases; Lymphoproliferative Disorders; Mice; Mice, SCID; Mitogen-Activated Protein Kinase 8; Rats; Signal Transduction; Viral Matrix Proteins | 2008 |